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In  the  spring  of  1928 the  accumulated evidence concerning the 
etiology of yellow fever presented seeming discrepancies which sug- 
gested that more than one independent disease had been investigated 
as yellow fever.  To help overcome this confusion the International 
Health Division of the Rockefeller Foundation undertook to  bring 
together in one laboratory  the yellow fever viruses of West Africa 
and South America and to determine their relationship,  The study 
was  begun  in  June,  1928, at  The  Rockefeller Institute  for  Med- 
ical Research. 
The  conflicting  evidence  referred  to  may  be  summarized  briefly. 
In Cuba in 1900 and 1901 the Yellow Fever Commission of the United States 
Army under Major Walter  Reed  (1)  found that  the etiological agent of yellow 
fever was present  in the circulating blood during the first  three  days of fever; 
that  it was not  cultivable  by any of the bacteriological methods used;  that  it 
would pass  a  Berkefeld  filter  capable  of holding  back Staphylococcus pyogenes 
aureus; and that it could be readily transferred from a sick person to a well one 
with  the production of infection,  by the  mosquito A~des aegypti.  The bite  of 
even one mosquito was sufficient to cause the disease. 
From 1918 to 1924 a leptospira was isolated by Noguchi and other investigators 
(2)  from patients  in outbreaks of yellow fever in Ecuador (Guayaquil),  Mexico 
(M6rida  and Vera  Cruz),  Peru  (Morrop6n),  and Brazil  (Palmeiras).  Like  the 
specific  agent studied by the commission under Waiter Reed this organism was 
present in the blood early in the disease,  it was not cultivable  in the ordinary 
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culture media for bacteria, and it was able to pass Berkefeld filters  (V and N). 
It seemed  to differ,  however, in not being easily transferable by A~des aegypti. 
Noguchi (3) found that he could infect guinea pigs with this leptospira, which he 
named Leptospira icteroides,  by means of the bites of A~des aegypti which had fed 
previously on a  patient  or on infected guinea pigs,  but  that  transmission  was 
obtained infrequently considering the number of mosquitoes employed.  Another 
difficulty in the way of accepting the organism as the causative agent of yellow 
fever was the uncertainty of the diagnosis in the cases in which leptospirae were 
isolated.  In the individual case, infectious jaundice, caused by Leptospira ictero- 
haemorrhagiae,  is ordinarily indistinguishable  from yellow fever on the basis of 
symptoms.  EUiott (4), who was associated with Noguchi in 1918 as clinician of 
the  commission which  studied  yellow  fever  in  Guayaquil,  held  the  following 
opinion: "Clinically yellow fever is similar to infectious jaundice.  The differences 
existing between the two diseases appear to be chiefly those of degree.  There is 
more marked jaundice  and less hemorrhage  in yellow fever than  in infectious 
jaundice."  In the differential diagnosis between these diseases the nature of the 
prevailing epidemic was of necessity frequently allowed to determine the decision 
with regard to the individual case.  To meet this difficulty Noguchi made com- 
parative studies of L. iaeroides and L. icterohaemorrhagiae  and decided (2)  that 
they  were  distinct  morphologically  and  serologically,  and  that  the  evidence 
appeared to warrant the conclusion that L. icteroides  is the cause of yellow fever. 
This view became generally accepted. 
In 1925 the West African Yellow Fever Commission of the Rockefeller Founda- 
tion undertook the study of a disease in West Africa known as yellow fever and 
indistinguishable from the yellow fever  in  South America by clinical or patho- 
logical characteristics.  As summarized by  Stokes,  Bauer, and  Hudson (5), 67 
cases of yellow fever were studied bacteriologically by Muller,  Kligler,  Sawyer, 
and Bauer between January,  1926,  and May,  1927.  Although a  large number 
of cultures were made and many guinea pigs inoculated, no leptospira could be 
isolated nor any other organism which could have a relation to the disease.  Yel- 
low fever in West Mrica was obviously not due to L. icteroides. 
In 1927 it was discovered by Stokes, Bauer, and Hudson (5)  that the monkey 
Macacus rhesus is susceptible to yellow fever.  Using this monkey as an experi- 
mental animal they found that the specific  agent of the yellow fever of Africa 
resembled that of the classic yellow fever studied by the army commission in Cuba 
in being present in the blood early in the disease, in not being cultivable, in ftltra- 
bility, and in ease of transference by means of A~des aegypti. 
In 1928 AragAo (6) transferred the yellow fever of South America from patients 
to Macacus rhesus monkeys during an epidemic in Rio de Janeiro.  The infectious 
agent was found to be filtrable and was easily transmitted by A~des aegypti.  A 
search for L. icteroldes  in 15 cases of yellow fever yielded negative results. 
In the  meanwhile  several  experimenters  made  observations  which  called  in 
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the Americas, as represented by the disease  studied by the commission  under Reed. 
Sellards (7) was unable to demonstrate by serological methods any relationship 
between a yellow  fever outbreak in Parahyba, Brazil, and L. icteroides or L.iaero- 
haemorrhagiae.  Theiler  and SeUards (8)  and Schiiffner and Mochtar  (9)  com- 
pared L. icteroides and L. icterohaemorrhagiae and obtained strong evidence of 
their serological identity. 
Attempts to transfer L. ic~eroides by means of A~des aegypti failed in the hands 
of a number of investigators (Kligler (10), Gay and Sellards (11), Schiiffner  and 
Mochtar (9), and Sawyer and Bauer (12)) and they became convinced that this 
mosquito is not suited to act as intermediate host for L. icteroides. 
When our experiments were undertaken there seemed to be need 
for further investigation of the  relationships of  the  "yellow fever" 
of West Africa, the  "yellow fever" of South America not due to  a 
leptospira, the "yellow fever" of the Americas apparently caused by 
a leptospira, and a hypothetical "yellow fever" in which the etiological 
factors of the two last mentioned diseases are both present. 
Collection of Strains of Yellow Fever Virus 
The strains of virus used in our experiments were the French and 
the Asibi from West Africa and the F. W. from Brazil. 
The French strain was given us by Dr. A. W. SeUards and Dr. Max Theiler 
of the Harvard Medical School.  It had been obtained originally from a yellow 
fever patient  in Senegal by Mathis,  Sellards, and Lalgret  (13).  During our 
experiments this strain was indistinguishable from the Asibi strain in its effects 
on monkeys. 
The Asibi strain was sent us from Lagos, Nigeria, by Dr. Henry Beeuwkes, 
Director of the West Mrican Yellow Fever Commission  of the Rockefeller  Founda- 
tion.  It had been obtained in the Gold Coast from an Mrican native during an 
attack of yellow fever, and had been used by Stokes, Bauer, and Hudson (5) in 
most of their experiments. 
The establishment in our laboratory of a strain of yellow fever virus 
from South America proved to be difficult.  We are indebted to Dr. 
F. L. Soper and Dr. H. Muench for obtaining for us a large number of 
specimens of blood from yellow fever patients in Rio de Janeiro.  We 
wish  to  acknowledge also our  special obligation to  Dr.  Clementino 
Fraga, Di~.ector  of the National Department of Health, and to Dr. 
Sinval Lins, Chief of the Communicable Disease Section of Hospital 
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free  access  to  the  patients.  Specimens  of  blood  and  tissues  from 
monkeys  experimentally  infected  with  yellow  fever  were  received 
through the  kindness  of Dr.  H.  de  B.  Arag~o of the  Oswaldo  Cruz 
Institute in Rio de Janeiro and of Dr. N. C. Davis and Dr. J. H. Bauer 
of  the  Yellow  Fever  Laboratory  of  The  Rockefeller  Foundation 
at  Bahia. 
The specimens of human blood from Rio de Janeiro were taken from 103 patients 
having yellow fever  or suspected  of having it.  A citrated specimen from each 
patient was received and also dried blood from three and clotted blood from four. 
Among the patients supplying the blood were at least two from whom yellow fever 
was transmitted to monkeys in Rio de Janeiro.  This was accomplished by blood 
inoculation  by Da Cunha and Muniz (14) in the case of F.W., andthrough the 
bites of mosquitoes by Arag~o (15) in the case of N.M.  The blood was drawn on 
the first day of the disease from 11 patients,  on the second from 37, on the third 
from 53, and on the fourth from one.  In one instance  the day of disease was 
not  recorded. 
As soon as received,  the specimens were injected into M. rhesus monkeys, in 
varying amounts, usually  ~ntraperitoneally,  rarely subcutaneously.  Of the  110 
specimens,  including  duplicates,  16  were  injected into  separate  animals.  The 
remaining 94 were divided into 14 groups and pooled, and part of each of the 14 
mixtures  was  injected  into  one  or  two monkeys.  In some  instances  animals 
which showed no symptoms were inoculated  later with another specimen as the 
number of available  monkeys was limited.  Test injections  with a known virus 
were not given at the end of the observation period to determine whether immunity 
to yellow fever had been established  as we had no yellow fever virus during the 
early part of the work.  The rectal  temperature of the monkeys under observa- 
tion was taken twice each day. 
The results  from the inoculation  of the specimens of human blood sent from 
Rio de Janeiro were  uniformly  negative.  Most of the monkeys developed no 
fever.  Six had isolated rises of temperature which seemed of no significance.  We 
concluded  that it was not practicable  to isolate strains of yellow fever from the 
blood of patients in South America while working at so great a distance from the 
source  of material. 
Attempts to bring in a strain of yellow fever already established  in monkeys 
finally  met with  success.  From Rio  de  Janeiro  Dr.  Aragao  sent  us  material 
from monkeys infected  with several strains  (F.W.,  N.M., N.M. and J.K., N.M. 
and D.A., J.K. and R.M.).  We received citrated, glycerinated,  and dried monkey 
blood (one specimen of each) under refrigeration;  an emulsion of mosquitoes which 
had fed on an infected  monkey; and monkey liver  which had been  refrigerated 
(5 specimens), ]~rozen (3), glycerinated  (3), dried  (2), and one kept at room tem- 
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intraperitoneally or subcutaneously.  Six of the animals died from causes other 
than yellow fever.  The other Animals remained normal except one. 
A monkey which had been inoculated with a  specimen of frozen liver, F.W. 
strain, tenth passage in monkeys, showed fever on the seventh day and recovered. 
After an observation period of 28 days from the date of inoculation this monkey 
was given a test injection of African yellow fever virus, Asibi strain, and was found 
to be immune.  The strain obtained by bleeding this monkey at the beginning of 
its fever was carried through many passages in this laboratory, and the  F.W. 
virus used in our experiments was derived from this succession. 
Like the African strains, the F.W.  strain thus procured could withstand long 
storage under suitable conditions.  At one time the strain was apparently lost, 
but was reestablished by inoculating a  monkey with  stored liver tissue.  The 
specimen of liver had been kept continually frozen for 67  days.  Between experi- 
ments this strain was successfully preserved in storage for varying intervals up to 
92 days in monkey blood dried in the frozen state by the methods used by Sawyer, 
Lloyd, and  Kitchen  (16) in preserving African strains  of yellow fever virus.* 
We have not yet tested older dried blood specimens of the F.W. strain by inocula- 
tion of monkeys. 
The material from Bahia, Brazil, consisted of 28 ~pecimens of blood and liver 
from 20 monkeys experimentally infected with yellow fever of the B.B.  strain 
(27 specimens)  and the S.R. strain (1 specimen).  These strains had been obtained 
from yellow fever patients  in Bahia,  Brazil, by Davis and Burke  (!7).  This 
material was injected into monkeys and the B.B. strain was established in our 
laboratory, but the virulence of this strain for monkeys was so low that it seemed 
unsuitable for our projected cross-immunity experiments. 
In the hands of Davis and Burke (17) the B.B. strain has shown a higher degree 
of virulence.  Immunity against African virus was possessed by four of eight 
animals that developed fever after inoculation by us with the B.B. strain specimens. 
This adds to the evidence supporting Davis (18) in his conclusion  that this strain 
is immunologicalty the same as African yellow fever virus. 
Bacteriological  Examinations 
The specimens of citrated human blood received from Rio de Janeiro 
were  tested  for  bacterial  contamination  by  inoculation  of  broth  or 
agar  slants.  Only  three  specimens  produced  visible  growths  and 
they  were  caused  by  three  different  organisms.  A  more  critical 
bacterial  examination  was  made  by  Frobisher  (19)  of  30  of  these 
specimens of human blood and also of the blood of I6 monkeys infected 
* A specimen of African yellow fever virus (French strain)  in monkey blood 
preserved in this way has been tested after one year in storage and found to be 
highly virulent for rhesus monkeys. 498  YELLOW FEVER 
with African or South American yellow fever virus and of the liver 
tissue  of  10  monkeys infected with  African  virus.  Cultures  were 
made  in  a  wide  variety  of  media,  includin.g  the  Noguchi  lepto- 
medium, and guinea pigs were inoculated.  The results were essen- 
tially  negative. 
Of the specimens of  citrated human  blood  sent  us  from  Rio  de 
Janeiro, 66 were examined also by H. R. Muller and E. B. Tilden (20) 
at The Rockefeller Institute  for  Medical  ResearCh.  Two of these 
specimens yielded  cultures  of  a  spiral  organism agreeing  with the 
cultures  of L.  icteroides  isolated in yellow fever  epidemics  by  Dr. 
Noguchi.  Both of the specimens containing leptospirae came from 
severe cases with the symptoms of yellow fever; one of the cases was 
fatal.  Both  specimens  were  among  the  first  36  examined, which 
group  was  included  in  the  103  specimens  inoculated by  us  into 
monkeys. 
Tests  of Monkeys  Immunized  with American  Yellow  Fever  Virus for 
Immunity to African Virus 
In order to show the relationship of American yellow fever to the 
African, monkeys were immunized with American yellow fever virus 
and afterward tested for susceptibility to African virus, and vice versa. 
In Table I are given the results of the tests of eleven monkeys which 
had exhibited fever after intraperitoneal inoculation with  the  F.W. 
strain of American yellow fever virus.  Monkeys which had not shown 
fever after inoculation with this strain were sometimes found to be 
immune to African virus and sometimes not.  They were all excluded 
from this experiment as some had probably not been infected. 
Three of the monkeys were inoculated a second time with the F.W. strain from 
5 to 7 weeks after the first inoculation, in order to make certain that they had 
become immune to American yellow fever virus.  To obtain additional evidence 
regardingthe immunity produced and a better idea of its degree, blood was taken 
from six of the animals between the 16th and 41st days after the last injection of 
American virus, and the serum was tested for protective power against African 
virus.  All eleven of the monkeys were tested by intraperitoneal injection of 
African virus when at least 30 days had elapsed after their last inoculation with 
American virus, and the high virulence  of the African  viru~ used was shown  by its 
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of observation after the test inoculation was 30 days or longer.  Only tempera- 
tures of 40°C. or over were accepted as fever unless otherwise stated. 
All  of  the  eleven  monkeys  immunized  against  American  yellow 
fever virus survived inoculation with a highly virulent strain of African 
yellow fever virus,  and  only  one  showed  fever within  the  period  of 
TABLE I 
Immunity to African Yellow Fever Virus in Monkeys after Infection with American 
Yellow Fever Virus 
Mon- 
key 
First inoculation with  Second inoculation with 
American virus  American virus 
Str~n 
F.W. 
F.W. 
F.W. 
F.W. 
F.W. 
F.W. 
F.W. 
F.W. 
F.W. 
F.W. 
F.W. 
Febrile period* 
5.5 to 12.0 
2.5 to 15.0 
2.5 to  9.0 
7.0 & 12.0 
7.5 to  9.5§ 
3.o§ 
2.0 to  8.5 
6.o to  7.s 
3.o to  4.5 
4.0§ 
4.0 to 12.o 
Strain  I  Febrile period* 
F.W.  11.0 to 13.0 
F.W.  None 
Not inoculated 
Not inoculated 
F.W.  I N6ne 
Not inoculated 
Not inoculated 
Not inoculated 
Not inoculated 
Not ifi~culated 
Not inoculated 
Protection test 
of  monkey's 
~ruD3t A  ¢,smql 
African  ~'irust 
Protected~ 
Protected 
Protected 
Protected~ 
Protected 
Not tested 
Protected~: 
Not tested 
Not tested 
Not tested 
Not tested 
Test of monkey 
for immunity by 
,  inoculation 
with African 
virus  (Asibi) 
Ily~D.une 
Immune 
Immune 
Immune 
Immune 
Immune 
Immune 
Immune[[ 
Immune¶ 
Immune 
Immune 
* Expressed in days after inoculation. 
Performed with Experiment IV; same methods, same virus (Asibi),  regular 
amount of serum, and same controls (Table IV). 
:~ Had one elevation of temperature; Monkey B on 14th day after inoculation, 
Monkey E on 7th, Monkey H on 8th. 
§ Maximum temperature 39.7°C. (Monkey G) or 39.9°C. (Monkey K). 
J] Observed for 24 days only. 
¶ Fever 4.0 to 6.0 day.  Observed for 12 days only. 
observation.  The sera of six of these monkeys taken before the  test 
inoculation  were  tested  for  power  to  protect  monkeys  against  the 
same  African  strain.  All  protected  against  death,  although  three 
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Tests  of  Monkeys  Immunized  with  African  Yellow  Fever  Virus  for 
Immunity to American Virus 
As it was a rare exception for a monkey to survive inoculation with 
fresh virus of the African  strains which we used  (French and Asibi), 
it was necessary in our  cross immunity  tests to use monkeys which 
TABLE  II 
Immunity to American Yellow  Fever Virus in Monkeys after Infection witk African 
Yellow Fever Virus 
Mo~ey 
Control: 
c§ 
First inoculation  with 
African  virus 
Strain  Febrile  period 
M  Asibi  None 
N  Asibi  None~ 
O  French  None~ 
P  French  Nonet 
Q  French  12.5 to 15.0 
R  French  6.0 to 7.0 
S  Asibi  5.0 
T  Asibi  3.0, 3.5 
U  French  1.5to5.0 
Second inoculation 
with Mrican  virus 
Strain  Febrile  period 
Asibi  None 
Asibi  1.5 
Asibi  None 
Asibi  None 
Asibi  None 
Asibi  4.5 
French  None 
French  None 
Not inoculated 
Protection test of 
monkey's  serum 
against American 
virus (F.W.) 
Not tested 
Not tested 
Not tested 
Not tested 
Not tested 
Not tested 
Not tested 
Not tested 
Doubtful~ 
Test of monkey  for 
immunity  b~¢ 
inoculation  w~th 
American  virus 
(F.W.) 
Immune*tJ 
Immune* 
Immune 
Immune 
Immune  H 
Immune 
Immune 
Immune 
Immune 
Febrile period 
2.5 to 15.0 
* Had received an injection of the B. B. strain of American virus but, as the 
controlmonkey  as well as the animal testedshowedno reaction, the monkey was 
reinoculated 14 days later with the F. W. strain. 
Protected by an injection of African immune serum from recovered African 
natives (Monkeys N, and P) or from immunized  Monkey A, Table IV (Monkey O). 
:~ Had irregular unexplained  rises of temperature from day of inoculation. 
§ Monkey C was control for the examination  of the sera of  Monkeys M, N, O, 
P, Q, R.  The other tests were made with the controls shown in Table V. 
11 Observation period only 20 days (Monkey M) or 21 days (Monkey Q). 
had  been protected  against  death  by injections  of Mrican  immune 
serum  or  which  had  received virus  attenuated  by  some method  of 
preservation  or by long  storage.  Nine  animals  immunized  against 
African  virus  were  available  for  testing.  Particulars  with  regard 
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Eight of the monkeys tested had been given a second injection of the African 
virus from 20 to 48 days after the first as a test of immunity to that virus.  The 
monkeys were tested by inoculation with American virus (F.W. strain) after an 
interval of between 31 and 39 days from the last injection of African virus, except 
in one instance in which the interval was  143 days.  They were kept under ob- 
servation for 30 days or more, except when otherwise stated in the table. 
Blood was taken from one of the anlmats before the test inoculation and the 
serum was tested for protective power against American virus.  As the monkey 
receiving this serum with the virus had irregular fevers not due to the yellow fever 
virus, it was impossible to know whether an attack of fever was caused by the 
virus and no conclusion could be drawn, as death does not ordinarily result from 
the F.W. virus in this laboratory. 
All  nine of the  monkeys immunized  against  African yellow fever 
were  free  from  fever following inoculation  with  the  F.W.  strain  of 
American  virus. 
In the cross immunity tests, monkeys immunized against American 
yellow fever virus resisted African yellow fever virus and, conversely, 
those immunized with the African virus resisted the American virus. 
Protective Power of American Yellow Fever Sera against African Virus 
and against Leptospirae 
A.  Sera Taken Soon after Undoubted Yellow Fever 
An  exceptional  opportunity  to  investigate  the  relationship  of 
American yellow fever to African yellow fever and to leptospiral jaun- 
dice was presented by an epidemic of yellow fever in Rio de Janeiro. 
Through the courtesy of Dr. H. de B. Arag~o  and Dr.  F. L. Soper we 
received 15 specimens of  serum  from  14  persons  who  had  recovered 
recently from yellow fever in that city.  They are listed in  Table III 
under the heading  "Recent  epidemic,"  and our  findings  with  regard 
~o these sera are summarized  there. 
In all the 14 cases a definite diagnosis of yellow fever had been made on clinical 
grounds.  In one case (N.M.)  the diagnosis  had been proven, for Aragao (15) 
had transferred the infection to a monkey by means of mosquitoes.  In eight 
cases the attack was described as severe; in six as mild. 
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TABLE  ~[I 
Protection by Sera of Persons Recovered  from American Yellow Fever against African 
Yellow Fever Virus and Leptosplra icteroides or L. icterohaemorrhagiae 
Serum  Time after 
attack 
Recent epidemic: 
N.M.  31 days 
C.F.  39 days 
D.A.  26 days 
M.A.  16 days 
(lst specimen) 
F.C.  10 days 
J. R.S.  85 days 
G.V.  15 days 
M.R.  49 days 
M.A.  40 days 
(2nd  specimen) 
J.M.  20 days 
M.M.  144 days 
M. J.S.  153 days 
R. B.S.  156 days 
J.M.  153 days 
C. W.G.  47 days 
Protection of  Protection of monkey  guinea  pig against  Experiment 
against yellow  fever virus*  leptospirae* 
I 
+ 
+ 
-(1.s)t 
+ 
+ 
+ 
-¶ 
+ 
+ 
+ 
-(3.S)§ 
-(2.0) 
-  (4.0)§ 
-(2.0) 
+ 
+ 
-(3.S)~ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-(4.5) 
-(4.0) 
+ 
-(4.S) 
m 
--  B 
N  B 
w  B 
--  D 
--  I  A 
+~  I  A 
--  I  A 
II  i  A 
m 
I  A 
I  A 
II  A 
II  B 
II  B 
-  -  +~  ii  B 
--  --  --  III  C 
+  +  +  III  C 
--  --  --  III  C 
-  t~  ~  m  c 
+  +  +  IV  C 
* The yellow fever virus was of the strains Asibi in Experiments I and IV and 
French in Experiments II and III.  The strains of leptospira used were Leptospira 
icteroides, Brazil 49, in Experiments A and B, and Leptospira icterokaemorrkagiae, 
Rat I, in Experiment C. 
J" The figure in parenthesis is the number of days from inoculation to the first 
observation of fever in column "Prevented Fever," and from inoculation to death 
in column "Prevented Death." 
Guinea pig had fever but survived and was found to be immune to a second 
injection of L. icteroicles. 
§ Temperature rose as high as 40°C. only once. 
I[ Guinea pig had fever, but died on second day Mter inoculation while being 
bled; too early for characteristic lesions. 
¶  Had unexplained occasional single elevations of temperature from the  1st 
to the 58th day after inoculation. 
** No fever observed. 
~f~ Guinea pig died from unknown cause on day following inoculation. SAW"YER~  KITCHF.N~  FROBISHER~  AND  LLOYD 
TABLE  III--Conduded 
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Serum 
)oubtful cases: 
Car. F. 
M.D. 
H.D. 
Dj. A. 
"ormer epidemics: 
G.E. 
C. H. H. 
D. O.L.  (1st test) 
D.  O.  L.,  double 
amount 
I.  J.  K.,  0.4  of 
amount 
P.  S.  R.,  double 
amount 
Time after 
attack 
i  brief 
i  brief 
i 
J  brief  i 
i  brief  i 
9  years 
5  years 
23  years 
8½ years 
30  years 
Protection of monkey 
against yenow fever virus* 
Prevented  Prevented 
fever  death 
-  (1.5)  -  (4.0) 
-(1.5)  -  (4.5) 
+  + 
+  + 
-  (5.0)  + 
-(2.o)  -(s.o) 
-- (2.0)  -- (9.0) 
-(4.0)  + 
+  + 
--(2.0)  --(4.5) 
guinea pig against 
Ieptospirae* 
-~: 
Protection of 
Experiment 
• 
III  C 
III  C 
III  C 
III 
B 
B 
B 
II 
II 
II 
IV 
III 
IV 
:~ No serum remained for test. 
West African Yellow Fever Commission of the Rockefeller Foundation in Lagos. 
The results of the tests made by the Commission in Africa were reported by Hud- 
son, Philip, and Davis (21).  They found that the sera of N.M., C.F., M.R., M.A., 
and J.M. protected monkeys agaimt injection of African yellow fever virus (Cases 
16,  15,  12,  14, and 17 in their series).  One of  the  sera, however, that of D.A. 
(Case 13 in their series) failed to protect either of two monkeys against the injec- 
tion of the virus.  Four of these sera, those of N.M., C.F., M.A., and J.M.,  were 
tested in guinea pigs against L. icterohaemorrhagiae, and in every case the Pfeiffer 
phenomenon was absent and the animal died of leptospirosis.  The results of the 
protection tests in monkeys were in agreement with those of the tests we performed 
independently in New York with the same sera, and their Pfeiffer tests gave results 
consistent with those we obtained using different strains of leptospira. 
Explanation of Tables III and IV.  The results of tests with the sera of persons 
who had recovered from American yellow fever for protective power against African 
yellow fever virus and against L. icteroides or L. icterohaemorrkagiae are shown 
in Tables III and IV.  The results of the tests of the sera themselves are in Table 
III and those of the corresponding control tests are in Table IV.  The tests for 
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TABLE  IV 
Control Tests in the Experiments Recorded  in Table III 
Serum 
Recovered  African  na- 
tive, K. S. 
Recovered  African  na- 
tive, K. Owe. 
Recovered  Mrican  na- 
tive, K. Ot. 
Monkey A, immunized 
to Mrican virus 
Normal rhesus  monkey, 
double amount 
Anti-icteroides,  double 
amount 
Anti-icteroides,  1 : 10 
dilution 
Anti-icteroides,  1:100 
dilution 
Normal horse 
Normal human, double 
amount 
Normal human, double 
amount 
Normal human, double 
amount 
Normal  human, double 
amount 
rime aft.el 
attar.k 
10 mos. 
9 mos. 
22 mos. 
Protection of monkey 
against yellow fever virus 
Prevente( 
fever 
+ 
-(6.5) 
+ 
--(2.5) 
-(2.5) 
-(i.s) 
-(1.s) 
-  (i.s) 
II 
Protection  of 
guinea pig  against 
leptospira 
?revented 
death  ~ 
+ 
+ 
+ 
--(4.5)  -- 
-(6.5)  + 
+ 
+ 
-(4.5)  - 
-  (4.0)  - 
-(3.5) 
-  (6.0) 
I 
Experiment 
2 
--  --  I 
-  +*l  II 
--  --  II 
--  --  IV 
+  + 
§ 
--  -}-* 
•  ~  .~.~ 
~.~  ~ 
B 
B 
C 
B 
B 
A 
C 
B 
A 
A 
II  C 
III 
IV 
* Guinea pig had definite febrile attack but survived and was found to be im- 
mune to a second injection  of L. icteroides. 
t No fever observed.  Death from leptospiral jaundice 5 days after inoculation. 
** Temperature rose only to 39.9°C. 
:~ Guinea  pig had no fever for 17 days, then developed fever and died 6 days later 
of pneumonia  and peritonitis, but without lesions suggesting leptospiral jaundice. 
§ Guinea pig had fever and died of peritonitis on the seventh day.  No lesions 
suggestive of leptospiral jaundice. 
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TABLE  IV~Colccluded 
Serum 
[o serum,  full amount 
of  virus 
[o serum, 0.I amount 
of  virus 
[o serum,  0.01  amount 
of virus 
[o serum, full amount 
of virus 
[o serum,  0.1  amount 
of virus 
[o serum, 0.01 amount 
of virus 
[o serum,  0.1  amount 
of virus 
[o serum,  full amount 
of virus 
[o serum,  0.01 amount 
of virus 
alt solution 
alt solution 
alt solution 
Time after 
attack 
Protection of  Protection of monkey  guinea pig against 
against yellow fever virus  leptospira 
Prevented  Prevented  ~ ~  ~  ~  ~  d,~  ~  ~  ~  ~.~ 
--(1.5)  --(5.0)  I  I 
-(2.0)  -(4.5)  I 
-(lO.O)  -(il.O)I  I 
i 
-(6.0)  +¶  n 
--(2.0)  --(4.0)  II 
II  -(8.5)  II 
- (3.0)**  - (5.0)  m 
-  (2.5)t~  -  (4.S)  IV 
-(2.5)  -(4.0)  IV 
u 
EXperiment 
A 
B 
C 
¶  Monkey survived, although it had received no serum. 
~t Temperature rose only to 39.8°C. 
:~: Guinea pig died on night following inoculation. 
designated by the Roman numerals I, II, III, and IV, and the tests for protec- 
tion against leptospirae were made in three experiments, A, B, and C.  In order 
to show which controls belong to each experiment the numbers and  letters iden- 
tifying them are given in the column headed "Experiment." 
The  sets  tested  were injected intraperitoneaUy into  M.  rhesus monkeys  in 
amounts of 1.5 cc. per kilogram of body weight except where otherwise stated in 
the column headed "Serum."  The expression "double amount" means that 3.0 
cc. per kilogram was given, and "0.4 amount" means 0.6 cc. per kilogram.  These 
variations in amount of serum do not apply to the tests with leptospirae.  The 
"time after attack" was measured from the onset of the disease to the time of 
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Inoculations of monkeys with African yellow fever virus were given subcutane- 
ously six hours after the serum had been given intraperitoneally.  The amount 
of the virus injected was  0.3  cc.  per kilogram of body weight in experiments 
I, II, and III, and 0.2 cc. per kilogram in Experiment IV. 
The temperatures of the monkeys were taken twice each day.  To eliminate 
the personal equation as far as possible, only temperatures of 40°C. or above were 
considered as signifying fever except when otherwise stated in the tables.  In the 
column headed "Prevented fever" the plus sign  (+)  signifies that  the monkey 
had no fever and remained well during an observation period of 30  days after 
inoculation.  The minus sign (-)  in this column indicates that fever developed, 
and was probably due to yellow fever, unless explained in a  footnote.  In the 
column "Prevented death"  a  plus sign (+)  shows that the animal did not die. 
Survival was  not  necessarily due  to  the  action of  the  serum,  for  very rarely 
recoveries follow infection with the strains of African virus in use, as for example 
in the case of one of the controls receiving no serum.  A minus sign (-)  in this 
column signifies that the monkey died of yellow fever.  The diagnosis in all fatal 
cases of yellow fever was determined by finding characteristic lesions on post- 
mortem examination and on histological examination of the tissues. 
In the tests of sera for their power to protect guinea pigs against leptospirae a 
strain of L. icteroides,  Brazil 49, was used in Experiments A  and B, and one of 
L. icterohaemorrh~giae, Rat I, in Experiment C.  Both these strains were given us 
by  H.  R.  Muller, of  The  Rockefeller  Institute  for  Medical Research.  Strain 
Rat I had been isolated recently from a wild rat of New York. 
In the Pfeiffer tests 1 cc. of the serum to be tested was mixed with 1 cc. of an 
active culture of leptospirae, and  1 cc. of the mixture was injected immediately 
into the peritoneal cavity of a  guinea pig.  Fluid was withdrawn from the peri- 
toneal cavity of the guinea pig 30, 60, 90, and 120 minutes after inoculation and 
examined under the dark-field  microscope.  If the Pfeiffer phenomenon was absent, 
the result was recorded with a  minus sign  (-)  under  "Pfeiffer phenomenon." 
In the cases in which the record shows a plus sign the Pfeiffer phenomenon was 
present and unmistakable. 
The guinea pigs which had been inoculated in the Pfeiffer tests were kept under 
observation  to  determine  whether  they  were  protected against  experimental 
leptospiral jaundice by the sera injected.  In the column "Prevented fever"  a 
plus sign means that the guinea pig remained free from fever and a  minus sign 
that it developed fever.  In the column "Prevented death" a plus sign indicates 
survival, not always due to the serum, and a minus sign means death from experi- 
mental leptospiral  jaundice.  Footnotes explain the irregular results.  The diagno- 
sis of leptospiral jaundice in the guinea pig was made by the observation of the 
jaundice,  extreme  hemorrhages,  and  other  characteristic lesions,  and  usually 
by the observation of leptospirae in the tissues or body fluids. SAWYER, KITCHEN, ]~ROBISHER, AND LLO~ZD  507 
The  tests of  the  sera  of the  fourteen persons  who  had  recovered 
recently from yellow fever in  the  epidemic  in  Rio  de/aneiro  gave 
the following results: 
10 persons--the serum protected against African yellow fever virus, but not 
against leptospirae (tests with L.  icteroides  in 8 instances and L.  ictero- 
haemorrhagiae  in 2). 
2  persons--the serum protected against  leptospirae but  not  against  African 
yellow fever virus (both tests with L.  icterohaemorrhagiae). 
2 persons--the serum protected against neither African yellow fever virus nor 
leptospirae (tests with L.  icteroides  in one instance and L.  icterohaemor- 
rhagiae in the other). 
The results with the second and third groups of the sera in the above 
classification were clear cut and regular.  Those with the first group 
showed a  few irregularities in the tests in guinea pigs, as is explained 
in the notes accompanying Table III. 
In two cases, in which the guinea pigs died too soon for diagnosis, the definitely 
negative Pfeiffer test may be accepted as indirect evidence of the lack of protec- 
tive power in the serum, since in the other cases negative Pfeiffer  tests were followed 
by failure to protect and positive Pfeiffer tests by protection of the guinea pigs. 
Two guinea pigs  inoculated with  serum  and leptospirae developed fever and 
recovered.  That occasional recoveries are to be expected after inoculation with 
the strain of L. icteroides  used, in the absence of a protective serum, is shown by 
the behavior of a control guinea pig which received the same strain with normal 
horse serum and recovered (Table IV). 
The two species of leptospirae,  L. icteroides  and L. icterokaeraorrkagiae,  appear 
to be so closely related that they may be used interchangeably in immunological 
tests for leptospiral jaundice, as in this investigation of ours, and we have already 
referred to the work of investigators who obtained strong evidence of their sero- 
logical identity.  It will be noticed in Table IV that anti-icteroides serum, even 
when diluted, gave positive Pfeiffer reactions with both  species  of leptospira. 
This serum had been prepared by The Rockefeller Institute by immunizing a horse 
against a number of strains of L. icteroides. 
The absence of protective power against African yellow fever virus 
in four of the sera from recent cases of yellow fever in Rio de Janeiro 
(D.A., M.J.S., R.B.S., and C.W.G.) is in our opinion strong evidence 
against the presence of yellow fever in these cases, in view of the evi- 
dence already presented showing that African yellow fever and Ameri- 
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sera  sent  from  Rio  de  Janeiro  should  be  from  cases  other  than  of 
yellow fever  casts no reflection on the ability of the diagnosticians; 
for in many cases it is impossible to distinguish by symptoms between 
yellow  fever  and  leptospiral  jaundice,  and  mild  yellow  fever  may 
simulate a number of infections. 
As evidence of the lack of protective power in these sera we have the results 
following the inoculation of one monkey in each case, and the confirmatory  observa- 
tions, already mentioned, of Hudson, Philip, and Davis (21) in the case of D.A. 
The evidence from the inoculation of one monkey in each case seemed conclusive, 
however, as there was no suggestion of even partial protection by amounts of serum 
varying from 3.2 cc. to 5.9 cc. according to the weights of the animals. 
Observations which bear on the reliability of such negative protection tests 
have been tabulated by Hudson (22) and relate to sera of 23 West African natives 
who had recovered recently from yellow fever during observed epidemics.  Of 
28 monkeys, each of which had received 4 cc. of serum and 0.25 cc. to 1.0 cc. of 
blood virus (Aslbi strain), only one succumbed  to yellow fever.  The possibility 
of error of diagnosis in the case of the person supplying the one negative serum 
cannot be completely ruled out.  Hudson gives the estimated number of spontane- 
ous recoveries of rhesus  monkeys after inoculation with the Asibi strain of virus 
as about two per cent. 
Two  of  the  sera  from  Rio  de  Janeiro  (iVI.J.S.  and  C.W.G.)  had 
strong protective power against L. icterahaemorrhagiae, and in one of 
these  cases  (C.W.G,)  the  occurrence of a  definite relapse  after  dis- 
charge from the hospital is against  the diagnosis of yellow fever and 
suggestive of leptospiral jaundice, which so commonly has  an after- 
fever.  H.R.  Carter  (23), after a  wide experience with yellow fever, 
said of that disease, "I have never seen a relapse, but other men have. 
They  must  be  rare."  Although  the  possibility  cannot  be  entirely 
excluded that  the protective substances in either serum were due to 
an earlier attack of leptospiral jaundice, it is highly probable that in 
both cases the illnesses taken for yellow fever were in  reality lepto- 
spiral  jaundice  (Well's  disease). 
M.J.S. had a mild attack and was discharged from the hospital as cured on the 
seventh day after the onset, according to data published by Barreto (24). 
C.W.G.  came to New York after his recovery and permitted us to draw an 
additional specimen of blood.  He also supplemented the information which had 
been sent us by Dr. F. L. Soper.  The illness of C.W.G.  was characterized by 
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second day, moderate albuminuria from the fourth day, and jaundice from the 
seventh.  During the first four days the symptoms were such that the physicians 
were of the opinion that the disease was not yellow fever, but on the seventh day 
a definite diagnosis of yellow fever was made.  The patient was allowed to get up 
on the 13th day and to leave the hospital on the 15th.  On reaching home he 
again developed high fever and headache.  On the 17th day he was able to leave 
his bed.  Convalescence  was slow, and he was still distinctly jaundiced on the 
48th day, when he visited our laboratory in New York.  In Rio de Janeiro he 
worked at the water front and docks in places where there were many rats.  An 
investigation of this case in Brazil has been published  by R. A. Warner (25). 
As the sera from most of the 14 persons in Brazil who had recently 
had symptoms like those of yellow fever possessed strong protective 
power against African yellow fever virus, the conclusion seems justified 
that the yellow fever of America is the same disease as that of Africa. 
The same  conclusion has been reached by Theiler and  Sellards  (26), 
Hudson, Bauer, and Philip  (27)  and Hudson, Philip, and Davis  (21) 
as the result of their protection tests with American sera. 
B.  Sera Taken Soon after Suspected  Yellow Fever 
Four of the sera sent us came from a town in southern Brazil, and were from 
cases in which yellow fever was only suspected.  In each case the illness was mild 
and a diagnosis could not be made from the symptoms.  These specimens were 
tested with the results recorded under the heading "Doubtful cases" in Table III 
Two of the sera protected completely against yellow fever and two did not protect. 
at all.  One of the sera which protected against  the virus and the two others were 
tested for power to protect against "L. icteroides, and none protected.  We were 
evidently dealing with two cases of yellow fever, and two cases of infection other 
than yellow fever or leptospiral jaundice. 
C. Sera Taken Long after Yellow Fever 
The  testing  of  the  sera  from  recent  cases  of yellow fever at  Rio 
de Janeiro indicated that the Brazilian disease was  the  same as that 
of Africa.  The assumption  was  also  that  it was  identical with  the 
disease studied by Reed in Cuba and suppressed by Gorgas in Panama. 
The fact, however, that the ocean passage between Senegal and Brazil 
may be as short as six days permits of the possibility of the transport 
of the African yellow fever to Brazil, although there is no evidence of 
this at the present time.  Fortunately the relationship of the present 
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need  not  be left to  speculation.  Direct  evidence has been obtained 
by the examination of the sera of persons who passed through attacks 
of American yellow fever many years ago. 
Serological evidence of the unity of the American yellow fever of the past and 
the African yellow fever of the present has been secured by Bauer and Hudson 
(28).  Two sera obtained 23 years after attacks of yellow fever in the Panama 
Canal Zone and one taken 26 years after an attack in Tampico, Mexico, protected 
monkeys against African yellow fever.  A fourth serum taken 26 years after yellow 
fever in New Orleans failed to protect.  The tests were made in duplicate. 
The results of the tests of five sera from persons who had had yellow 
fever in  the  Americas many years ago are  given  under  the  heading 
"Former  epidemics"  in  Table  III.  The  particulars  regarding  the 
sources  of  these  sera are  as  follows: 
G.E. had yellow fever in La Union, Salvador, in July, 1919, soon after arriving 
from Honduras.  The attack was very severe and lasted 14 days.  It was char- 
acterized by much vomiting,  heavy albuminuria,  and jaundice.  According  to 
the patient there were other cases of yellow fever in La Union and in Honduras 
at the time.  Blood was obtained for us by Dr. J. E. Eimendorf, Jr., and informa- 
tion regarding the case was supplied by Dr. Peraita Lagos.  The interval between 
the attack and the bleeding was 9 years and 3 months. 
C.H.H. had yellow fever in Aracajfi in the State of Sergipe,  Brazil, in May, 
1923, according to his statement.  We are indebted to Dr. B. E. Washburn and 
Dr. Hargreaves of Kingston, Jamaica, for obtaining blood.  The blood was drawn 
5 years after the attack. 
D.O.L. had a very severe attack of yellow fever in the city of Panama in June 
1905.  He was attended by several doctors who had had a large experience with 
yellow fever, including  Colonel  W. C. Gorgas, and Dr. H. R.  Carter.  We are 
indebted to Dr. W. E. Decks and Dr. R. C. Connor for putting us in touch with 
D.O.L., and to Captain J. W. Smith of the Medical Corps of the U. S. Army for 
drawing a specimen of his blood.  The interval between the attack of yellow fever 
and the drawing of blood was 23 years and 5 months. 
I.J.K. contracted yellow fever in Morrop6n, Peru,  in April, 1920, during an 
epidemic, and had a mild attack.  He spent a few months in West Africa in 1926. 
In his case the interval between the disease  and the bleeding was 8 years and 
7 months.  A different specimen of serum of I.J.K. was tested by Hudson, Bauer, 
and Philip (27) and found to protect against African virus, Asibi strain. 
P.S.R. had yellow fever in Havana, Cuba, in May,  1899, 30 years before the 
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The results obtained in these tests were as follows: 
Serum taken 8½ years after an attack of yellow fever in Peru pro- 
tected  a  monkey completely against  African yellow fever.  Serum 
taken 9 years after yellow fever in Salvador permitted the appearance 
of fever in the monkey but prevented death.  A  specimen obtained 
23 years after an undoubted attack of yellow fever in Panama failed 
to protect when injected in the usual amount, but prevented death, 
while permitting fever,  when  used  in  double  quantity.  The  same 
amount of  normal  human  serum  failed  to  prevent  the  death  of  a 
control animal in this experiment and in each of three other experi- 
ments  (Table IV).  A  serum  taken five years after yellow fever in 
Northern Brazil failed to protect.  The evidence with regard to the 
diagnosis in this case was meager.  Serum taken 30 years after yellow 
fever in  Cuba did not protect. 
The  results  obtained in  these  tests  and  those  of  the  other  in- 
vestigators  cited  show  the  historic yellow fever of America to have 
been the same as the present African yellow fever. 
Protective Power of African Yellow Fever Sera against American  Virus 
If we were right in our conclusion, derived from observation of the 
protective power  of American  sera  against African virus,  that  the 
yellow fever of America is the same as that of Africa, then the sera 
of  persons who have recovered  from  yellow fever in Africa  should 
protect likewise against American yellow fever virus. 
To demonstrate this by experiment proved difficult  owing to the low virulence 
of the F.W. strain of American  yellow  fever virus for monkeys, as the strain exists 
in this laboratory.  Only twice in our experience  has death resulted from the inocu- 
lation of a monkey with the F.W. strain.  In using this strain in protection tests 
it was necessary, therefore, to base our conclusions  on the presence or absence of 
fever in the experimental animals after inoculation.  Under  these circumstances 
the results of the tests would of necessity be inconclusive  in relation to the indi- 
vidual specimen of serum, but they should permit conclusions with regard to a 
group of sera when compared with an adequate series of control tests. 
In Table V are shown the results of tests of the sera of six natives of the Gold 
Coast of West Africa.  All of these persons had had yellow fever in observed 
yellow fever epidemics.  We are indebted to Dr. Henry Beeuwkes, Director of 
the West African Yellow Fever Commission  of the Rockefeller Foundation, for 
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TABLE  V 
ProtectionbySera~PersonsRecoveredfromAfrican  YellowFeveragainstAmerican 
Yellow F~er Virus 
Serum 
Mrican natives: 
K. Ot. 
K.B. 
K. Owir. 
J.o. 
K.N. 
T.C. 
2ontrols: 
American, recent re- 
covery, M. A. 
American, recent re- 
covery, C. W. G., 
double amount 
Auti-icteroides, 
double amount 
Normal human, 
double amount 
Protected 
monkey from 
fever after 
Time from  inoculation 
attack  with 
to  American 
bleeding  yellow fever 
virus, F.W. 
strain* 
22 mos.  + 
23  "  + 
20  "  + 
19  "  + 
30  "  + 
33  "  +§ 
40 days  + 
47  ',  -0a)ll 
-(3  S)l~ 
-  (4.o)11 
Result of later 
test inoculation 
of monkey 
with African 
virus, 
Asibi strain 
No reaction 
No reaction 
Survived$ 
No reaction 
No reaction 
No  reaction 
Survived$ 
No reaction 
No reaction 
Results of other tests of the sera 
Did not protect against L. 
ict.eroides (Table IV) 
Protected  against  African 
yellow  fever  virus 
(Asibi)  t 
Protected  against  African 
yellow  fever  virus 
(Table III) 
Protected against L. ictero- 
hemorrhagiaej  but  not 
African yellow  fever virus 
(Table III) 
Protected  against L. ictcr- 
aides and L. icterohemor- 
rhagiae, but not African 
yellow fever virus (Table 
rv) 
Similar specimens in Table 
IV 
* The F. W. strain showed low virulence for monkeys and did not cause any 
deaths during this experiment. 
t Tested in a later experiment with controls.  Monkey showed fever but was 
protected against death. 
:~ Had brief fever reaching 40°C. but recovered. 
§ Had no fever but died on 25th day of observation  from cause other than yel- 
low fever. 
H  Fever indefinite or absent.  The highest temperature of the monkey in the 
case of C. W. G. was 39.8°C.; in the case of the anti-icteroides serum, 39.7°C.; 
in the case of the normal human serum, 39.9°C.; in the case of the small dose of 
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TABLE  V~Conduded 
Serum 
Controls--Continued: 
Normal rkesus mon- 
key, double 
amount 
No  serum, full 
amount of  virus 
No  serum, 0.01 
amount of virus 
Thne from 
attack 
to 
bleeding 
Protected 
monkey  from 
fever after 
inoculation 
with 
American 
yeUow fever 
virus,  F.W. 
strain* 
--  (4.0) 
-  (4.o)  ~ 
-(3.s)lI 
Result of later 
test inoculation 
of monkey 
with  African 
vlr115 
Asibi strain 
No reaction 
No reaction 
Results  of other tests of the sera 
Similar specimens in Tabh 
IV 
¶ Died from dysentery on 28th day after inoculation. 
The methods of performing these tests and tabulating the results are in general 
the same as in  the  previous  experiments (Tables III and IV).  The regular 
amount of serum injected into the monkeys was l.S cc. per kilogram of body weight, 
and the double amount was 3.0 cc.  The amount of virus-bearing blood injected 
was uniformly 0.4 cc. per kilogram, and it was injected subcutaneously six hours 
after the serum had been given intraperitoneally. 
The results of the tests, though clearly unreliable in the individual 
case on account of the low virulence of the F.W. strain of virus used, 
show  that  the  African  sera  as  a  group  possessed  protective power 
against  American yellow fever virus.  In  no  case  did  fever appear 
in a  monkey which had  received one of these  six sera.  The three 
control animals which received the full amount of virus without serum 
or after normal human or monkey serum all showed rises of tempera- 
ture to 39.9°C. or over at the time when fever would be expected as 
the result of the inoculation.  These observations are in agreement 
with the stronger evidence obtained by testing American sera against 
African virus. 
Differences between the American and African Strains  of Yellow Fever 
in Their  Virulence for Monkeys 
The two African strains we used in our  experiments (French and 
Asibi) were similar to each other in virulence for monkeys, but they 514  YELLOW FEVER 
differed markedly in this respect from the one American strain (F.W.). 
To facilitate comparison, we have summarized our experience with the 
inoculation of rhesus  monkeys with the Asibi and F.W.  strains. 
In doing so we have considered only those cases in which the inoculum was 
blood taken on the first day of fever from monkeys experimentally infected with 
yellow fever in this laboratory.  The amount of blood was not less than 0.1 cc., 
expressed as undiluted whole blood.  If citrated blood was injected, the specimen 
was not over 24 hours old, and, if dried blood was used, it was prepared by drying 
in vacuum in the frozen state and was not over 100 days old.  In fatal cases the 
animals were allowed to die or were killed when moribund. 
Of 24 monkeys inoculated with African virus of the Asibi strain, all came down 
with yellow fever and only one survived.  Of 20 monkeys receiving American 
virus of the F.W. strain, 15 developed fever and two of these died.  These two, 
Monkeys V and W, had received dried blood 94 and 63 days old, respectively. 
In the cases of those animals  that showed temperatures of at least 40°C., the 
incubation periods for the Asibi  strain were,  minimum  1.5  days, maximum 6, 
and average 2.7; for the F.W. strain, minimum 1.5 days, maximum 12, and average 
4.3.  The intervals between inoculation and death were, for the animals inoculated 
with the Asibi strain, minimum 2.5 days, maximum 10.5, and average 5.  The 
two animals  which  died after receiving  the F.W.  strain did so 4.5  and 8 days 
after inoculation. 
The Asibi  strain  of African  virus  proved  to  have  a  much  higher 
virulence for monkeys than the F.W. strain of American virus.  The 
former caused death in 23  of 24 monkeys inoculated,  and  the latter 
in only 2 of 20.  It does not follow, however that  there is  a  similar 
difference between these  strains in  their virulence for man,  nor that 
these  strains  are  representative  in  virulence  of  the  African  and 
American  strains  in  general.  Dr.  N.  Paul Hudson  tells  us  that  the 
figures of the laboratory of the West African Yellow Fever Commis- 
sion of the Rockefeller Foundation showed, up to the end of 1928, that 
there  was  a  marked  variation  in  the  virulence  of  African  strains 
for Macacus rhesus.  A  strain  (H.P.) obtained from a  fatal case in a 
European killed only one-third of the monkeys inoculated with blood 
drawn  from infected monkeys at  the  time  of fever.  The mortality 
was low also when this strain was transmitted from animal to animal 
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Comparison of the Lesions Produced by African and American Strains 
of Yellow F ever Virus 
The gross and microscopic lesions produced by the Asibi and French 
strains of African yellow fever virus in our monkeys were in general 
those described by Hudson (29) for experimental yellow fever as pro- 
duced in M. rhesus by the Asibi strain.  The two animals (Monkeys 
V and W) which died as the result of inoculation with the F.W. strain 
of American virus showed gross and microscopic lesions such as are 
produced by  the  African  strains.  One  animal  (Monkey X)  killed 
during  a  mild  attack  following inoculation  with  the  F.W.  strain 
showed only very  slight changes. 
Da Cunha and Munlz (30) speak of the varying extent of the liver 
lesions in monkeys after inoculation with a Brazilian strain of yellow 
fever virus.  In some animals they found extensive necrosis of the 
hepatic cells  and none in others.  Although they found that  their 
virus possessed less virulence than an African strain, it was sufficient 
at times to cause early death with extensive lesions like those following 
inoculation with the Mrican strain. 
CONCLUS~ONS 
1.  The yellow fever now in South America, the present yellow fever 
of Africa and the historic yellow fever of Panama and other American 
countries are  the  same  disease.  This  conclusion is  based  on  cross 
immunity tests in monkeys with strains of yellow fever virus from 
Africa  and  Brazil  and  on  tests  of  sera  from  25  persons,  who had 
recovered from yellow fever in various places and at various times, 
for  the  power  to  protect  monkeys  against  African  or  Brazilian 
virus  strains. 
2.  Cases of leptospiral jaundice (Well's disease) were present among 
those  diagnosed as  yellow fever in  the  recent  epidemic in  Rio  de 
Janeiro.  This  is  shown by the isolation of  cultures  of leptospirae 
from the blood of two patients by H. R. Muller and E. B. Tilden of 
The Rockefeller Institute, and by the demonstration by us of protective 
power against  leptospirae and  absence of protective power against 
yellow fever virus in the sera from two persons after recovery.  The 
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blood of  occasional patients in  past  epidemics of  yellow fever in a 
number of American countries indicates that leptospiral jaundice was 
present then as well and was diagnosed clinically as yellow fever. 
3.  The absence of protective power against  leptospirae shown by 
the Brazilian sera which protected against yellow fever virus and the 
absence  of  protective  power  against  yellow  fever  virus  in  the  sera 
that protected against leptospirae point to the probability that Ameri- 
can yellow fever is not the combined effect of leptospirae and yellow 
fever virus.  The position of L. icteroides, isolated by Noguchi during 
yellow  fever  epidemics,  now appears  to be not that of a  secondary 
invading microorganism in cases of virus yellow fever, but that of the 
incitant of a  form of infectious jaundice, sometimes fatal, often coin- 
cident in its appearance with typical yellow fever and apparently indis- 
tinguishable from it clinically.  This leptospiral disease has not hitherto 
been separated from true yellow fever.  Noguchi's discoveries become, 
therefore, of the greatest  significance in respect to the epidemiology 
and  causation of yellow fever and of infectious jaundice, previously 
confused one with  the  other.  In  all  outbreaks  of  supposed yellow 
fever hereafter the existence of the two kinds of jaundice, one due to 
yellow fever virus and the other to leptospirae will have to be taken 
into  account.  Only  the  former  probably  is  spread  by  mosquitoes 
and requires anti-mosquito measures for its control. 
4.  The only difference observed by us between the American and 
African strains of yellow fever virus was a  pronounced difference in 
virulence  for  monkeys.  The  virulence  of  the  two  Mrican  strains 
studied was very high while that of the one American strain was highly 
variable  and usually low. 
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